EXPLORE PAE PRODUCTS
Set Up | Access | Catheters and Guidewires | Embolotherapy | Hemostasis
From set-up and access to hemostasis and including the first and only embolotherapy product with FDA clearance to treat symptomatic BPH via PAE, Merit offers your tools a la carte, or in several convenient packs.
SET UP
Prepare and protect your patients efficiently and safely.
PRODUCT | RADIAL | FEMORAL |
Embosphere® Procedure Pack – combines the basic products for any embolization procedure into one convenient pack. |
✔ | ✔ |
✔ | ✔ | |
✔ | ||
✔ |
ACCESS
Achieve quick and effective access.
PRODUCT | RADIAL | FEMORAL |
✔ | ||
✔ | ||
✔ |
CATHETERS AND GUIDEWIRES
Reach challenging anatomy with accuracy.
PRODUCT | RADIAL | FEMORAL |
✔ | ✔ | |
✔ | ✔ | |
✔ | ||
✔ | ✔ | |
✔ | ||
✔ | ||
✔ | ✔ | |
✔ | ||
✔ | ✔ |
EMBOLOTHERAPY
Treat your patients with predictable outcomes.
Read the press release announcing Merit Medical’s Embosphere® Microspheres Receive FDA 513(f)(2) (de novo) Classification for Prostatic Artery Embolization Indication.
HEMOSTASIS
Achieve controlled hemostasis accurately, quickly, and comfortably.
PRODUCT | RADIAL | FEMORAL |
✔ | ||
✔ | ||
✔ |
PHYSICIAN EDUCATION & RESOURCES
Physician Resource Center
Merit offers an extensive Physician Resource Center to support you in your PAE procedures. Downloadable resources include:
- Data & Studies
- Patient Education
- Referring Physician Materials
- Reimbursement Support
- Clinical Resources
- CMS Look-up Tool
Think PAE™
Learn the minimally invasive technique of Prostatic Artery Embolization (PAE). The ThinkPAE™ education course features numerous cases, didactic presentations including anatomy and patient identification, and hands-on training with simulators utilizing actual PAE cases.
PATIENT RESOURCES
Ask4PAE aims to educate patients and their families about PAE as a treatment option for BPH. The program includes Ask4PAE.com, as well as patient brochures and other awareness tactics.
For more information please refer to Instructions for Use. Consult product labels and inserts for any indications, contraindications, potential complications, warnings, precautions and directions for use.
References
- McWilliams, J. P., Kuo, M. D., Rose, S.C., Bagla, S., Caplin, D. M., Cohen, E. I., Faintuch, S., Spies, J. B., Saad, W. E., Nikolic, B. (2014). Society of Interventional Radiology position statement: prostate artery embolization for treatment of benign disease of the prostate. Journal of Vascular and Interventional Radiology, 25: 1349-1351. http://dx.doi.org/10.1016/j.jvir.2014.05.005 http://www.scvir.org/clinical/cpg/SIR_Pos_Statmt_PAE_Benign_dis_Prostate.pdf
- Patel, N. D., & Parsons, J. K. (2014). Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian Journal of Urology, 30(2): 170-176. doi: 10.4103/0970-1591.126900
- Krista, A. R., Arnold, K. B., Schenk, J. M., Neuhouser, M. L., Weiss, N., Goodman, P., Antvelink, C. M., Penson, D. F., & Thompson, I. M. (2007). Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. The Journal of Urology, 177(4): 1395-1400